CimaVax-EGF, the lung cancer vaccine developed by Cuba’s Center of Molecular Immunology is the very first therapeutic cancer vaccine. It targets non-small-cell lung carcinoma,...
CIMAVAX-EGF, an oncology vaccine, was developed in Cuba for the treatment of small cell lung cancer. Clinical trials have been underway in Canada, the...